ResearcherUniversity of British ColumbiaNo recent work listed

Sharon M. Gorski

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3821-8289; OpenAlex author ID A5018920739. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper

Papers 1

Loss of ATG4B and ATG4A results in two-stage cell cycle defects in pancreatic ductal adenocarcinoma cells. Last author DOI 10.1242/jcs.260644 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Paalini Sathiyaseelan · 1 shared paper, 2023 · strength 0.15
- Paper Loss of ATG4B and ATG4A results in two-stage cell cycle defects in pancreatic ductal adenocarcinoma cells. DOI 10.1242/jcs.260644 ↗
Steve E. Kalloger · 1 shared paper, 2023 · strength 0.15
- Paper Loss of ATG4B and ATG4A results in two-stage cell cycle defects in pancreatic ductal adenocarcinoma cells. DOI 10.1242/jcs.260644 ↗
David F. Schaeffer · 1 shared paper, 2023 · strength 0.15
- Paper Loss of ATG4B and ATG4A results in two-stage cell cycle defects in pancreatic ductal adenocarcinoma cells. DOI 10.1242/jcs.260644 ↗
Daniel John Renouf · 1 shared paper, 2023 · strength 0.15
- Paper Loss of ATG4B and ATG4A results in two-stage cell cycle defects in pancreatic ductal adenocarcinoma cells. DOI 10.1242/jcs.260644 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.